Home > Boards > US Listed > Biotechs > Applied DNA Sciences Inc. (APDN)

Yeah WhyTest, on the British/Dubai excipient test.... been

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
mcsharkey Member Profile
 
Followed By 21
Posts 6,784
Boards Moderated 1
Alias Born 05/14/11
160x600 placeholder
Applied DNA Sciences Announces Closing of Upsized $12.0 Million Underwritten Public Offering Business Wire - 11/15/2019 12:08:00 PM
Applied DNA Sciences Announces Pricing of Upsized $12.0 Million Underwritten Public Offering Business Wire - 11/13/2019 9:20:00 AM
Registration of Additional Securities (up to 20%) (s-1mef) Edgar (US Regulatory) - 11/13/2019 9:13:26 AM
Successful DNA Tagging of Leather at One of the World’s Largest Tanneries Business Wire - 11/12/2019 9:03:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/8/2019 4:17:47 PM
Applied DNA Sciences Announces Appointment of Scott L. Anchin to Board of Directors  Business Wire - 11/8/2019 3:22:00 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/8/2019 3:15:19 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/1/2019 5:22:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/31/2019 4:07:01 PM
Applied DNA Sciences Announces 1-For-40 Reverse Stock Split Business Wire - 10/31/2019 1:00:00 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 10/25/2019 4:28:35 PM
Applied DNA Receives Notice of Allowance on Patent Protecting its CertainT® Platform in Cellulosic Fibers and Materials Business Wire - 10/22/2019 8:30:00 AM
Applied DNA Partners with Molecular Isotope Technologies to Elevate CertainT® for Brand Assurance and Provenance Business Wire - 10/16/2019 5:30:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/8/2019 4:02:30 PM
Molecular Tagging of Pharmaceutical Excipients Utilizing Applied DNA’s Technology Published in Peer-Reviewed Journal Business Wire - 10/4/2019 5:00:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 10/3/2019 4:03:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/3/2019 6:32:21 AM
Applied DNA Receives Extension from Nasdaq Business Wire - 10/3/2019 5:00:00 AM
LineaRx’s iCTC Platform for Isolation of Circulating Tumor Cells Shows Superior Correlation over PSA as a Biomarker in Pros... Business Wire - 10/1/2019 8:30:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 9/26/2019 5:23:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/25/2019 4:03:37 PM
Applied DNA Receives $1 Million Order to Supply SigNature® T Molecular Taggant for 2019-2020 Cotton Harvest Season Business Wire - 9/24/2019 9:00:00 AM
LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction Business Wire - 9/19/2019 4:00:00 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 9/18/2019 5:30:08 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/17/2019 4:02:08 PM
mcsharkey   Monday, 10/07/19 03:08:18 PM
Re: whytestocks post# 56596
Post # of 56886 
Yeah WhyTest, on the British/Dubai excipient test.... been there in a Long Island test funded by Stonybrook. Can't find that whitepaper at moment.

If you're voting, I'm against any REVERSE SPLIT and thus against doing the split solely to stay on the NASDAQ. Hayward insinuated a LOT WAS ABOUT TO HAPPEN, annnddddd, doubting that unfortunately.

Still have some weeks to go till the PROXY VOTE is counted. PROPOSAL 2 does extend our laying in LIMBO a while longer. NASDAQ gave us OUT till end of the YEAR. I'm good with PROVISION 2.

Just so you know:)
GLTUA

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist